Indian firms want to rebrand the country as the next big destination for Western pharmaceutical and biotechnology companies looking to outsource drug development. In recent months, several Indian ...
Hosted on MSN10mon
Indian pharma companies to post revenue growth of 8-10% in FY2025; US & Europe growth momentum to moderate, says ICRAIndian pharmaceutical companies’ revenues are expected to grow by 8-10 per cent in FY2025, posting a YoY increase of 13-14 per cent in FY2024, said a report by ICRA. ICRA studied its sample set ...
Indian pharma expected to grow at 9-10% in FY26, says Ind-Ra Ratings: Our Bureau, New Delhi Friday, February 7, 2025, 11:45 Hrs [IST] Credit rating firm India Ratings and Research ...
Nandita Vijayasimha, Bengaluru Monday, February 10, 2025, 08:00 Hrs [IST] ...
By establishing dedicated ESG committees, setting measurable milestones, and aligning with international reporting standards, Indian pharmaceutical companies can enhance their attractiveness to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback